Hypertension (high blood pressure) decisions — 2025

The Board of Veterans' Appeals remands the claims for service connection for various conditions, including coronary artery disease, Parkinson's disease, hypertension, diabetes mellitus type II, and others, due to pre-decisional duty to assist errors.

The Board denied the Veteran's claim for a clothing allowance for Sunscreen SPF 30 as there is no evidence that he was prescribed sunscreen for a service-connected disability.

The Board remands the Veteran's claim for service connection for hypertension due to a duty to assist error, requiring additional evidence and records.

The Board remands the claims for further development, including obtaining additional evidence and opinions regarding the Veteran's claimed conditions and toxic exposures during service.

The Board granted an initial rating of 10 percent for service-connected hypertension, resolving reasonable doubt in the Veteran's favor.

The Board granted initial disability ratings for diabetic peripheral neuropathy of the right and left upper extremities, right and left lower extremities involving femoral and sciatic nerves, and a 70 percent rating for service-connected other specified depressive disorder with anxious distress (moderate), as well as a compensable rating for hypertension.

The Board denied the Veteran's request for an earlier effective date for the award of a 10 percent evaluation for hypertension, as there was no factually ascertainable increase in the disability prior to July 5, 2023.

The Board granted an effective date of August 8, 2022, for the award of service connection for hypothyroidism and a 10 percent evaluation for hypertension. Service connection was also granted for erectile dysfunction as secondary to service-connected conditions, and special monthly compensation was awarded.

The Board denied an earlier effective date for service connection for heart disability and hypertension, as the only basis on which service connection may be granted is under the provisions of the PACT Act, which became effective on August 10, 2022.

The Board denied service connection for hypertension, a higher rating for PTSD, and the reduction in rating for lumbosacral strain. The claims for service connection for GERD, erectile dysfunction, headaches, and higher ratings for bilateral lower extremity radiculopathy were remanded.

The Board granted service connection for erectile dysfunction (ED) as secondary to the Veteran's service-connected pituitary mass, but denied increased ratings for chronic sinusitis, deviated nasal septum with rhinitis, chronic pharyngitis with a history of strep throat and rhinitis, pituitary mass with migraine headaches, hypertension, hypothyroidism, lumbosacral strain with intervertebral disc syndrome and degenerative disc disease, left lower extremity radiculopathy of the femoral nerve, and left lower extremity radiculopathy of the sciatic nerve.

The Board granted service connection for coronary artery disease, status post dual chamber ICD placement residual scar, type II diabetes mellitus, and hypertension with an effective date of October 29, 2020.

The appeal of the claim for service connection for monoclonal gammopathy of unknown significance (MGUS) is dismissed as it has been granted in full.

The Board granted service connection for hypertension under the PACT Act, effective August 10, 2022. The claim based on a different filing date was remanded.

The Board denied earlier effective dates for service connection and ratings, but granted a 10 percent rating for hypertension from May 25, 2021.

The Board granted service connection for a heart condition manifest by cardiac arrhythmia, diabetes mellitus, type II, prostate cancer, hypertension, and eczema based on presumptive exposure to herbicide agents during active service.

The appeal concerning the issues of entitlement to service connection for hypertension and coronary artery disease is dismissed due to the Veteran's death.

The Board granted service connection for hypertension, as secondary to the Veteran's service-connected hypothyroidism with obesity as an intermediate step.

The Board denied an earlier effective date for the 100 percent disability rating for PTSD prior to February 1, 2023, and remanded several service connection claims.

The Board remands the claims for service connection for hypertension, erectile dysfunction, and tinnitus due to a need for additional development of evidence.